CardioVascular BioTherapeutics, Inc. (CVBT) news stock charts
CardioVascular BioTherapeutics, Inc. (CVBT/CVBT.OB) Investment Summary:
CardioVascular BioTherapeutics, Inc., a development stage biopharmaceutical company, focuses on developing and marketing protein drug candidates used in the treatment of cardiovascular disease. The company uses an active pharmaceutical ingredient, the 141 acidic human form of fibroblast growth factor-1, in its drug candidates, which facilitates the growth of new blood vessels in the heart tissues and organs with an impaired vascular system. Its products under development include CVBT-141A, a Phase I clinical trial completed product for use in the treatment of severe coronary heart disease; and CVBT-141B, a Phase I clinical trial completed product for the treatment of wound healing; CVBT-141C...www.cvbt.com
22 Employees
Founded in 1998
CARDIOVASCULAR BIOTHERAPEUTI (CVBT:OTC)
LAST $0.31 USD
CHANGE TODAY +0.065 26.53%
VOLUME 1.0M
As of 3:03 PM 03/18/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of CARDIOVASCULAR BIOTHERAPEUTI (CVBT)
|
OPEN
$0.25
|
PREVIOUS CLOSE
$0.25
|
|
|
DAY HIGH
$0.31
|
DAY LOW
$0.24
|
|
|
52 WEEK HIGH
10/7/09 - $0.40
|
52 WEEK LOW
04/30/09 - $0.12
|
|
|
MARKET CAP
46.4M
|
AVERAGE VOLUME 10 D
621.5K
|
|
|
EPS TTM
$-0.08
|
SHARES OUTSTANDING
154.7M
|
|
|
CVBT Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for CARDIOVASCULAR BIOTHERAPEUTI (CVBT)
CardioVascular BioTherapeutics Inc., Annual General Meeting, May 18, 2010
12/8/2009
CardioVascular BioTherapeutics Inc., Annual General Meeting, May 18, 2010, at 09:00 US Pacific Time.
CardioVascular BioTherapeutics, Inc., Annual General Meeting, Nov 23, 2009
07/3/2009
CardioVascular BioTherapeutics, Inc., Annual General Meeting, Nov 23, 2009, at 09:00 Pacific Daylight. Location: Corporate Headquarters, 1625 Village Center Circle, Las Vegas, NV 89134, United States.
CardioVascular BioTherapeutics Deleted From OTCBB
04/24/2009
CardioVascular BioTherapeutics, Incs common stock has been deleted from OTC Bulletin Board effective April 27, 2009 on account of its failure to comply with NASD 6530. The company has been added to NBB.
CardioVascular BioTherapeutics, Inc. financial resources
CVBT Competitors
| Company | Last | Change |
| Boston Scientific Corp | $7.02 USD | +0.065 |
| GenVec Inc | $2.75 USD | -0.0401 |
| Genzyme Corp | $57.42 USD | +0.38 |
| Johnson & Johnson | $65.01 USD | +0.36 |
| Sanofi-Aventis SA | €56.56 EUR | +0.28 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | CVBT | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | -- | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
CVBT |
||
|
CVBT transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About CardioVascular BioTherapeutics, Inc.
Would you like to leave a comment about CardioVascular BioTherapeutics, Inc. CVBT/CVBT.OB
Find out what social network information about CardioVascular BioTherapeutics, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides CardioVascular BioTherapeutics, Inc.'s Stock there is more great penny stock and market information at Realpennies